Pilot Study Evaluating the Acceptability and Absorption of the Bioactive Compounds of a Russian Tarragon Nutrasorb Bar

Pennington Biomedical Research Center

Status: Completed

Conditions: Diabetes Prevention

Treatments: Dietary Supplement: Nutrasorb bar

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT05130593

PBRC 2020-022

5P50AT002776-15 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to make a bar from the soy-protein Russian Tarragon complex (PMI-5011/Nutrasorb) that is safe and acceptable for consumption, and to test the blood levels of plasma bioactive (DMC-2) after ingestion of the bar. The PMI-5011/Nutrasorb comes from a plant source called Artemisia dracunculus. This plant has a long history of medicinal (health) and culinary (food) use and has been reported as effective as a traditional treatment for diabetes in various parts of the world.

Full description

Phase 1

Test Day: Fasting Visit (nothing to eat or drink other than water beginning at 10 pm the night before the test day); visit will be approximately 1 ½ hours.

The following procedures will be done on the Test Day:

• Informed consent will be signed by those agreeing to participate.
• Body weight and height will be measured (body mass index will be calculated from these measures).
• Participants will provide a list of any medications they are currently taking.
• Blood pressure and pulse will be measured.
• Taste test of the study bar will be conducted.
• Participants will answer questions regarding the appearance, smell, taste, texture, aftertaste, and pleasantness of the bar.

Phase 1 participants may be asked to return up to two additional times to complete the taste test and questions again. This will occur if the product is found unacceptable and will be completed after a new bar is produced.

Phase 2

Screening Visit: Fasting Visit (nothing to eat or drink other than water after 10 pm the night before the Screening Visit); visit will be approximately 1 ½ hours.

The following procedures will be done on the Screening Visit:

• Informed consent will be signed by those agreeing to participate.
• Body weight and height will be measured (body mass index will be calculated from these measures).
• Blood pressure and pulse will be measured.
• Medical history questionnaire will be completed.
• Blood will be drawn (approximately 2 teaspoons) to assess overall health.

Test Day: Fasting visit (nothing to eat or drink other than water after 10 pm the night before the Test Day); visit will be approximately 4 hours and will be completed within 30 days after Screening Visit.

The following procedures will be done on the Test Day:

• Blood will be drawn from an IV line placed in the participant's arm to assess the level of nutrients, blood sugar levels, and insulin levels from the study bar 10 minutes before the bar is consumed, immediately after the bar is consumed, and 30, 60, 120, and 180 minutes after the bar is consumed. A total of approximately 6 teaspoons of blood will be drawn for this Test Day.
• Participants will answer questions regarding the appearance, smell, taste, texture, aftertaste, and pleasantness of the bar.
• Participants will be asked about any side effects and how they feel throughout the Test Day.

Enrollment: 20 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy males or females between 18 and 50 years of age inclusive.
• Body mass index between 20-30 kg/m2.

Exclusion criteria

• Pregnant or currently lactating.
• Taking any prescription medications.
• Taking any over-the-counter medications that cannot be stopped for test days.
• Allergic to any ingredients contained in the bar.
• Other conditions or situations that would interfere with the study or the participant's safety as determined by the investigators.
• Participants in Phase 1 of the study may not participate in Phase 2 of the study.

Trial design

20 participants in 1 patient group

Nutrasorb bar evaluation

Description:

Participants in Phase 1 will taste test the bar for acceptability. Participants in Phase 2 will consume the bar and have blood samples drawn for measurement of safety parameters (glucose and insulin) and bioactive compounds (DMC-2).

Treatment:

Dietary Supplement: Nutrasorb bar